OrthoPediatrics designs and markets orthopedic implants, instruments and related systems built specifically for children rather than scaled-down adult devices. The product range covers trauma, deformity correction, spine and sports-medicine needs in pediatric orthopedics. Its customers are primarily children’s hospitals and orthopedic surgeons who treat growing patients with anatomy and growth considerations distinct from adults.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 61.1 | — | -7.1 | — |
| Q3 2025 | 61.3 | — | -11.8 | — |
| Q4 2025 | 61.6 | — | -10.1 | — |
| Q1 2026 | 59.4 | — | -10.7 | — |
| Q2 2026 | 70.5 | 15.4% | -7.2 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: SOPHiA GENETICS SA (SOPH), Shenandoah Telecommunications Company (SHEN), DBV Technologies S.A. (DBVT), Sagimet Biosciences Inc. (SGMT), Unity Bancorp, Inc. (UNTY), Kearny Financial Corp. (KRNY)